4//SEC Filing
Poulton Stuart 4
Accession 0001209191-23-014872
CIK 0001503802other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:38 PM ET
Size
4.9 KB
Accession
0001209191-23-014872
Insider Transaction Report
Form 4
Poulton Stuart
EVP, Chief Development Officer
Transactions
- Award
Common Stock
2023-02-28+95,000→ 159,131 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001942597
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:38 PM ET
- Size
- 4.9 KB